Lewis Hall Freda C Insider Trades

Insider Trading History

Track insider trading activity for Lewis Hall Freda C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $577 38,466 shares
Last Trade
Aug 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662 35,000 shares
$0.02
$0.02
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $637k 38,466 shares
Last Trade
Aug 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$573k 35,000 shares
$16.36
$16.56
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $31k 38,466 shares
Last Trade
Aug 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.9k 35,000 shares
$1.74
$0.80
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $12.1k 15,000 shares
Last Trade
Aug 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.4k 15,000 shares
$1.89
$0.80
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $248k 15,000 shares
Last Trade
Aug 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 15,000 shares
$16.36
$16.56
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $225 15,000 shares
Last Trade
Aug 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228 15,000 shares
$0.02
$0.02
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Director
Holding Value $0 0 shares
Last Trade
Jul 01, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.7M 78,755 shares
$46.99
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Director
Holding Value $1.16M 24,727 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 10,060 shares
$46.22
$46.99
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $62.9k 36,979 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2k 36,979 shares
$0.98
$1.70
Murphy Canyon Acquisition
Murphy Canyon Acquisition MURF
Director
Holding Value $876k 51,991 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$802k 47,612 shares
$16.85
$16.85
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $41.9k 51,991 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 47,612 shares
$13.35
$0.80
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $861k 51,991 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$779k 47,612 shares
$16.36
$16.56
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $780 51,991 shares
Last Trade
Mar 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$509 47,612 shares
$0.01
$0.02
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $338k 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7M 420,000 shares
$106.50
$0.80
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Director
Holding Value $6.3k 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.24k 420,000 shares
$0.01
$0.02
Murphy Canyon Acquisition
Murphy Canyon Acquisition MURF
Director
Holding Value $7.08M 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.08M 420,000 shares
$16.85
$16.85
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Director
Holding Value $6.96M 420,000 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.87M 420,000 shares
$16.36
$16.56
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Director
Holding Value $353k 437,976 shares
Last Trade
Nov 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.4M 437,976 shares
$137.85
$0.80
Murphy Canyon Acquisition
Murphy Canyon Acquisition MURF
Director
Holding Value $7.38M 437,976 shares
Last Trade
Nov 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.38M 437,976 shares
$16.85
$16.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up